To gain further insights into the potential role of ACSBG1 in FA metabolism, and to assess its potential as a therapeutic target in XALD, we produced an ACSBG1 knockout (Acsbg1−/−) mouse. This evidence concerns the gene ACSBG1 and X-linked adrenoleukodystrophy.